8 Jan 2016

Transparency notification

Read More
18 Dec 2015

Transparency notification

Read More
18 Dec 2015

Acquisition of own shares

Read More
8 Dec 2015

Transparency notification from BlackRock Inc.

Read More
3 Dec 2015

UCB reinforces its commitment to epilepsy research with a strong presence at the 2015 American Epilepsy Society annual meeting

Read More
25 Nov 2015

Divestiture of Kremers Urban to Lannett completed

Read More
20 Nov 2015

Acquisition of own shares

Read More
20 Nov 2015

UCB receives positive EU CHMP opinion for CIMZIA® (certolizumab pegol) to treat severe, active and progressive rheumatoid arthritis in DMARD-naïve patients

Read More
20 Nov 2015

CHMP recommends EU approval for UCB’s new drug brivaracetam for people with epilepsy

Read More
17 Nov 2015

Transparency notification of The Capital Group Companies, Inc.

Read More
Subscribe to